SINTOFARM SA BUCURESTI

SINT

| | Healthcare

Financial Reports

Price Chart

Sector: Healthcare

Based on Market Cap
LEADER
ATB
Antibiotice S.A.
1,464M
BIO
Biofarm S.A.
1,345M
RMAH
Farmaceutica REMEDIA S.A.
86M

ETAPA 1 • MUST HAVE

2/8
Healthy Leverage (Debt/Equity)
1.00
Target: < 1.5
Gross Margin vs Industry
0.0% vs 0.0%
Target: > 0.0%
Operating Cash Flow vs Profit
0%
Target: > 1.0
Free Cash Flow vs Profit
0%
Target: > 0.8
ROIC (Return on Capital)
0.00%
Target: Positive
ROIC vs WACC
ROIC: 0.0% / WACC: 1.6%
Target: > WACC
ROE (Return on Equity)
0.0%
Target: > 10%
EBITDA Positive
0.00M
Target: > 0

ETAPA 2 • CRITERII

2/9
Interest Coverage
Target: > 3x • 0.0x
Miss
Net Margin vs Industry
Target: > 0.0% • 0.0%
Passed
ROA vs Industry
Target: > 5.5% • 0.0%
Miss
Current Ratio
Target: > 1.5 • N/A
N/A
Assets Growth (5y)
Target: > 0% • 0.0% CAGR
Miss
FCF CAGR (5y)
Target: > 5% • 0.0%
Miss
EV/EBITDA vs Industry
Target: < Industry • 0.0 vs 0.0
Miss
Net Debt / EBITDA
Target: < 3 • 0.00
Passed
Revenue CAGR (5y)
Target: > 5% • 0.0%
Miss

SNAPSHOT COMPANIE

Capitalizare
0.00B RON
EBITDA
0.00M
P/E Ratio
0.00
PEG Ratio
0.00
Dividend Yield
0.00%
Beta
-0.14
Valoare Intrinsecă (Graham)
0.00 RON
Discount
0.0%

financial report

Annual Data
Metric 2025 TTM 2025 2024 2023
Fiscal Year 2,025 2,025 2,024 2,023 2,022
Fiscal Quarter H2 H2 H2 H2 H2
Marketcap 13,512,674 27,218,386 20,848,126 16,678,500 5,829,754
Market Cap Growth -35.19% - 25.00% 186.09% -
Enterprise Value 12,711,804 27,502,426 20,769,995 16,422,330 5,571,403
Last Close Ratios 350.00% 705.00% 540.00% 432.00% 151.00%
Pe 41.32 83.23 - 34.23 8.41
PS Ratio 1.05 2.11 1.69 1.45 0.56
PB Ratio 1.26 2.53 2.00 1.56 0.57
P/TBV Ratio 1.27 2.55 2.02 1.58 0.58
P/FCF Ratio - - 42.26 51.30 -
P/OCF Ratio - - 30.27 38.36 -
EV/Sales Ratio 0.99 2.13 1.68 1.43 0.53
EV/EBITDA Ratio 11.90 25.75 40.03 13.51 3.91
EV/EBIT Ratio 21.82 47.22 621.88 22.54 6.06
EV/FCF Ratio - - 42.10 50.52 -
Debt / Equity Ratio 0.19 0.19 0.19 0.19 0.20
Debt / EBITDA Ratio 1.86 1.86 3.83 1.63 1.40
Debt / FCF Ratio - - 4.03 6.11 -
Net Debt / Equity Ratio 0.03 0.03 0.12 0.15 0.18
Net Debt / EBITDA Ratio 0.27 0.27 2.48 1.30 1.27
Net Debt / FCF Ratio - - 2.61 4.87 -0.93
Asset Turnover 89.60% 89.60% 86.60% 80.80% 75.90%
Inventory Turnover 104.50% 104.50% 85.40% 90.70% 106.10%
Quick Ratio 2.08 2.08 1.83 1.82 1.59
Current Ratio 2.95 2.95 2.84 2.79 2.46
Roe 3.09% 3.09% -2.17% 4.68% 6.86%
Return on Assets (ROA) 2.53% 2.53% 0.15% 3.20% 4.18%
Return on Invested Capital (ROIC) 4.41% 4.54% 0.28% 6.01% 7.77%
Return on Capital Employed (ROCE) 0.05 0.05 0.00 0.07 0.09
Earningsyield 2.42% 1.20% -1.10% 2.92% 11.89%
FCF Yield - - 2.37% 1.95% -33.15%

Price History

Oct 12, 2023 — Apr 23, 2026 37 Records
Date Open High Low Close Volume
2026-04-23 6.55 6.55 6.55 6.55 2
2026-04-17 6.50 6.50 6.50 6.50 500
2026-04-14 9.10 9.10 9.10 9.10 50
2026-03-26 7.00 7.00 7.00 7.00 40
2026-03-13 10.00 10.00 9.95 9.95 1,100
2026-03-12 6.45 9.95 6.45 9.95 73
2026-03-04 9.15 9.15 9.15 9.15 27
2026-03-03 8.40 8.40 8.40 8.40 20
2026-02-26 8.40 9.00 8.40 9.00 18
2026-02-23 6.95 6.95 6.95 6.95 3
2026-02-17 6.90 7.25 5.25 7.25 345
2026-02-16 7.50 7.50 7.50 7.50 10
2026-02-13 5.80 5.80 5.80 5.80 40
2026-02-11 4.60 5.40 4.60 5.40 101
2026-01-12 4.22 4.22 4.22 4.22 73
2025-11-11 3.50 3.50 3.50 3.50 1
2025-02-07 4.30 4.30 4.30 4.30 54
2025-01-31 5.20 5.20 5.20 5.20 15
2025-01-29 6.90 6.90 3.82 4.00 214
2024-10-30 5.40 5.40 5.40 5.40 40
2024-10-17 5.00 5.00 5.00 5.00 40
2024-10-16 4.70 4.70 4.70 4.70 47
2024-10-15 4.70 4.70 4.70 4.70 3
2024-06-14 4.80 4.80 4.80 4.80 6
2024-05-29 6.20 6.20 6.20 6.20 50
2024-05-27 5.50 5.50 5.50 5.50 39
2024-05-20 5.50 5.50 5.50 5.50 6
2024-05-09 5.50 5.50 5.50 5.50 64
2024-05-08 5.50 5.50 5.50 5.50 40
2024-04-29 4.80 4.80 4.80 4.80 40
2024-04-22 5.55 5.55 5.55 5.55 172
2024-02-08 5.55 5.55 5.55 5.55 50
2024-01-17 5.60 5.60 5.60 5.60 10
2023-11-14 4.32 4.32 4.32 4.32 40
2023-11-13 5.50 5.50 5.50 5.50 40
2023-10-17 4.40 4.50 4.40 4.50 50
2023-10-12 3.50 3.50 3.50 3.50 39